Skip to content

Medical-device intelligence

JFJ: Catalytic Methods, Amylase

FDA product code JFJ: Catalytic Methods, Amylase. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
JFJ
FDA device name
Catalytic Methods, Amylase
Device class
2
Regulation number
862.1070
Medical specialty
Clinical Chemistry
Review panel
CH

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore clinical chemistry records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

99 clearance records and 2 recall records in the covered releases, across 62 source company names and 1 product codes. Dated history runs from Jul 5, 1977 to May 26, 2022.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
JFJ · Catalytic Methods, Amylase992

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

101 matching records
Device / recordCompany in FDA recordSourceSource date
Amylase2K210633 · JFJAbbott Ireland Diagnostics Division510(k)May 26, 2022FDA decision date
Pancreatic Amylase AY3855 batch 480483 Pancreatic Amylase Ethylidene Blocked-pNPG7 ReagentZ-2924-2020 · JFJRANDOX LABORATORIES, LTD.RecallAug 29, 2020FDA record creation date
Atellica CH Amylase_2 (AMY_2)K191454 · JFJSiemens Healthcare Diagnostics, Inc.510(k)Jul 30, 2019FDA decision date
alpha-AMYLASE DIRECT, alpha-AMYLASE EPS, alpha-AMYLASE PANCREATIC, BILIRUBIN DIRECT, BILIRUBIN TOTALK182474 · JFJBiosystems S.A.510(k)May 2, 2019FDA decision date
HITACHI CLINICAL ANALYZER S TEST REAGENT CARTRIDGES FOR LD AND AMYK130685 · JFJHitachi Chemical Diagnostics, Inc.510(k)Aug 9, 2013FDA decision date
ELTECH CHINICAL SYSTEM AMYLASE SL ELITECH CLINICAL SYSTEMS ELICAL2 ELTECH CLINICAL SYSTEMS ELITROL I AND ELITROL IIK122858 · JFJElitechgroup510(k)Oct 3, 2012FDA decision date
SYNCHRON SYSTEMS G7 AMYLASE (AMY7) REAGENT WITH MODEL(S) A71607K091846 · JFJBeckman Coulter, Inc.510(k)Oct 16, 2009FDA decision date
EASYRA AMYLASE, BUN, GLU-H, TRIG, URIC REAGENTK080823 · JFJMedica Corp.510(k)Nov 17, 2008FDA decision date
Roche LIPC Lipase Colorimetric Reagent; Catalog Number: 03029590322. Roche Diagnostics Corp., Indianapolis, IN 46250Z-0688-2008 · JFJRoche Diagnostics Corp.RecallFeb 8, 2008FDA classification date
AMYLASE EPS REAGENTK070064 · JFJThermo Fisher Scientific510(k)May 22, 2007FDA decision date
ABX PENTRA AMYLASE CP; MULTICAL; N CONTROL; P CONTROL; CLEAN-CHEM CP; CLEAN-CHEM 99 CPK062180 · JFJHoriba Abx510(k)Oct 2, 2006FDA decision date
SENTINEL PANCREATIC AMYLASEK051447 · JFJSentinel Ch. Srl510(k)Jan 26, 2006FDA decision date
AMYLASE LIQUID REAGENT, MODEL A532-200K040920 · JFJTeco Diagnostics510(k)May 10, 2004FDA decision date
VITALAB AMYLASE REAGENTK040534 · JFJClinical Data, Inc.510(k)Mar 11, 2004FDA decision date
WIENER LAB AMILASA 405 AA LIQUIDAK023549 · JFJWiener Laboratories Saic510(k)Dec 9, 2002FDA decision date
JAS AMYLASE LIQUID REAGENTK020282 · JFJJas Diagnostics, Inc.510(k)Feb 28, 2002FDA decision date
SYNCHRON SYSTEMS PANCREATIC AMYLASE (PAM) REAGENTK013978 · JFJBeckman Coulter, Inc.510(k)Jan 15, 2002FDA decision date
WIENER LAB. AMILASA 405 CINETICA AA, WIENER LAB.AMILASA 405 CINETICA UNITEST,WIENER LAB.AMILASA CINETICA AAK013101 · JFJWiener Laboratories Saic510(k)Nov 16, 2001FDA decision date
GENZYME DIRECT-AMYLASE TEST REAGENTK011843 · JFJGenzyme Corp.510(k)Aug 10, 2001FDA decision date
MODIFICATION TO REFLOTRON AMYLASE, CAT. 1200658K011145 · JFJRoche Diagnostics Corp.510(k)Jun 25, 2001FDA decision date
INFINITY AMYLASE REAGENT (PROCEDURE NO. 580/568)K001569 · JFJSigma Diagnostics, Inc.510(k)Jun 26, 2000FDA decision date
CARESIDE AMYLASEK990025 · JFJCareside, Inc.510(k)Feb 8, 1999FDA decision date
WAKO L-TYPE AMYLASEK984184 · JFJWako Chemicals USA, Inc.510(k)Jan 13, 1999FDA decision date
AMYK981653 · JFJAbbott Laboratories510(k)Aug 28, 1998FDA decision date
AMYK981216 · JFJAbbott Laboratories510(k)Jun 8, 1998FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗